KR102596573B1 - Cosmetic composition containing Cyperus sanguinolentus extract for skin whitening - Google Patents
Cosmetic composition containing Cyperus sanguinolentus extract for skin whitening Download PDFInfo
- Publication number
- KR102596573B1 KR102596573B1 KR1020200167170A KR20200167170A KR102596573B1 KR 102596573 B1 KR102596573 B1 KR 102596573B1 KR 1020200167170 A KR1020200167170 A KR 1020200167170A KR 20200167170 A KR20200167170 A KR 20200167170A KR 102596573 B1 KR102596573 B1 KR 102596573B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- weight
- cosmetic composition
- sanguinolentus
- bangdong
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 54
- 239000000203 mixture Substances 0.000 title claims abstract description 37
- 239000002537 cosmetic Substances 0.000 title claims abstract description 18
- 230000002087 whitening effect Effects 0.000 title claims description 16
- 241001087928 Cyperus sanguinolentus Species 0.000 title claims 3
- 102000003425 Tyrosinase Human genes 0.000 claims abstract description 18
- 108060008724 Tyrosinase Proteins 0.000 claims abstract description 18
- 230000000694 effects Effects 0.000 claims abstract description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 37
- 239000002904 solvent Substances 0.000 claims description 11
- 239000007864 aqueous solution Substances 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 4
- 230000002401 inhibitory effect Effects 0.000 abstract description 6
- 210000003491 skin Anatomy 0.000 description 19
- 238000009472 formulation Methods 0.000 description 17
- 238000004519 manufacturing process Methods 0.000 description 16
- 238000002360 preparation method Methods 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 239000006210 lotion Substances 0.000 description 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 10
- -1 foundation Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 239000006071 cream Substances 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 6
- 241000237858 Gastropoda Species 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 235000013376 functional food Nutrition 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 244000149170 Pycreus sanguinolentus Species 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000008099 melanin synthesis Effects 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 229960000271 arbutin Drugs 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000010411 cooking Methods 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 235000011194 food seasoning agent Nutrition 0.000 description 3
- 235000013882 gravy Nutrition 0.000 description 3
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 3
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 3
- 229960004705 kojic acid Drugs 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 3
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 241001597062 Channa argus Species 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 2
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 229960004337 hydroquinone Drugs 0.000 description 2
- 235000015243 ice cream Nutrition 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- 235000012149 noodles Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229960004441 tyrosine Drugs 0.000 description 2
- 235000015192 vegetable juice Nutrition 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000817044 Cyperus pacificus Species 0.000 description 1
- 244000075634 Cyperus rotundus Species 0.000 description 1
- 235000016854 Cyperus rotundus Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 241000828585 Gari Species 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241000378107 Lilium catesbaei Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 235000015197 apple juice Nutrition 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940079894 benzophenone-9 Drugs 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 235000015190 carrot juice Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 235000012495 crackers Nutrition 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- QDCHWIWENYCPIL-UHFFFAOYSA-L disodium;4-hydroxy-5-(2-hydroxy-4-methoxy-5-sulfonatobenzoyl)-2-methoxybenzenesulfonate Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC(S([O-])(=O)=O)=C(OC)C=C1O QDCHWIWENYCPIL-UHFFFAOYSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 235000019674 grape juice Nutrition 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 208000031066 hyperpigmentation of the skin Diseases 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000015193 tomato juice Nutrition 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Abstract
본 발명은 방동사니대가리 추출물을 함유하는 조성물에 관한 것으로서, 상기 방동사니대가리의 추출물, 이 중에서도 잎과 줄기는 티로시나아제의 활성을 억제하여 피부 상태를 개선하는 다기능성 화장료 조성물로 용이하게 이용가능하다. The present invention relates to a composition containing an extract from the head of Bangdong sani, especially the leaves and stems, which can be easily used as a multifunctional cosmetic composition that improves skin condition by inhibiting the activity of tyrosinase.
Description
본 발명은 방동사니대가리(Cyperus sanguinolentus) 추출물을 함유하는 피부미백용 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition for skin whitening containing Cyperus sanguinolentus extract.
피부의 과색소 침착은 피부의 염증 반응 이후의 체내 호르몬 이상, 유전질환 및 자외선 조사 등의 여러 요인에 의해 발생하며, 주된 요인은 멜라닌 색소 합성 및 분포 이상에 의한 것이다. 멜라닌은 멜라닌 세포 내에서 티로신(tyrosine)이 티로시나제(tyrosinase)의 작용에 의해 도파퀴논(dopaquinone)으로 전환되고, 이후 상기 도파퀴논이 효소의 작용 및 자발적인 산화 반응에 의하여 멜라닌으로 전환되며 생성된다.Hyperpigmentation of the skin is caused by various factors such as hormonal abnormalities in the body following an inflammatory reaction of the skin, genetic diseases, and ultraviolet irradiation. The main factor is abnormal melanin pigment synthesis and distribution. Melanin is produced by converting tyrosine into dopaquinone within melanocytes by the action of tyrosinase, and then dopaquinone is converted into melanin by the action of enzymes and spontaneous oxidation reactions.
멜라닌 생성의 억제 방법으로는 다음과 같은 방법들이 있는데, 첫번째 방법은, 자외선을 차단하여 멜라닌 생성의 주원인을 제거하는 것으로, 광산란제 또는 광차단제를 함유한 화장료를 제조하여 미백 반응을 유도할 수 있다. 두번째 방법은, 티로시나제가 활성을 나타내기 위해 필요한 코어 탄수화물의 합성을 저해함으로써 멜라닌 생성을 억제하는 방법으로, 글루코사민(glucosamine)과 같은 화합물을 이용할 수 있다. 세번째 방법은, 멜라닌 세포에 대하여 특이적인 독성을 갖는 물질을 이용하여 상기 멜라닌 생성 세포의 세포분열을 방해하는 방법으로, 하이드로퀴논(hydroquinone)과 같은 화합물을 이용할 수 있다. 네번째 방법은, 멜라닌 생성에 관여하는 효소인 티로시나제의 기능을 방해하는 방법으로, 코직산(kojic acid) 또는 알부틴(arbutin)과 같은 화합물을 이용할 수 있다. 그 밖의 방법으로는, 생성된 멜라닌을 환원시키는 방법도 있다. 상기 방법 중에서 하이드로퀴논과 코직산 또는 알부틴과 같은 화합물을 이용할 때, 천연물 유래의 화합물을 사용할 수도 있으나, 합성 화합물을 이용할 수도 있다. 대표적으로 이용되는 합성 화합물로는 상기에 언급된 하이드로퀴논과 코직산 또는 알부틴 이외에도, 4-n-부틸레조시놀(4-n-butylresorcinol), 퀘르세틴(quercetin), 캠페롤(kaempferol) 등이 있는데, 상기 합성 화합물들은 미백 효과가 좋기는 하지만 피부 자극에 따른 제품 안전성 문제로 인해 그 사용에 한계가 있었다. 특히, 합성 4-n-부틸레조시놀은 제품 생산시 안정성이 떨어져 쉽게 갈변이 되며, 고농도로 사용할 때에는 피부자극이 나타나기도 한다. 따라서, 이러한 단점을 해결하기 위해, 감마리노렌산을 사용하여 4-n-부틸레조시놀을 리포좀화하는 방법이 개시된 바 있었으나(대한민국 등록특허 제10-0751883호), 자극성을 완전히 없애는 것은 불가능하였다.There are the following methods to inhibit melanin production. The first method is to block ultraviolet rays to remove the main cause of melanin production. A whitening reaction can be induced by producing cosmetics containing light scattering agents or light blockers. . The second method is to suppress melanin production by inhibiting the synthesis of core carbohydrates necessary for tyrosinase to be active, and can use compounds such as glucosamine. The third method is a method of interfering with cell division of melanin-producing cells using a substance that has specific toxicity to melanocytes, and a compound such as hydroquinone can be used. The fourth method is to interfere with the function of tyrosinase, an enzyme involved in melanin production, and can use compounds such as kojic acid or arbutin. Another method is to reduce the produced melanin. When using compounds such as hydroquinone, kojic acid, or arbutin in the above method, compounds derived from natural products may be used, but synthetic compounds may also be used. Representative synthetic compounds used include, in addition to hydroquinone, kojic acid or arbutin mentioned above, 4-n-butylresorcinol, quercetin, kaempferol, etc. Although the above synthetic compounds have a good whitening effect, their use is limited due to product safety issues due to skin irritation. In particular, synthetic 4-n-butylresorcinol has poor stability during production, easily turns brown, and may cause skin irritation when used in high concentrations. Therefore, in order to solve these shortcomings, a method of liposomalizing 4-n-butylresorcinol using gamma-linolenic acid has been disclosed (Korean Patent No. 10-0751883), but it was impossible to completely eliminate irritation. .
방동사니대가리(Cyperus sanguinolentus)는 전국에 분포하는 일년초로서, 잎은 밑부분에 달리며 폭 2-3mm로서 밑부분이 통같고 화경보다 짧으며 엽초는 녹색이 돌지만 밑부분의 것은 갈색이다. 꽃은 7-10월에 피고 포는 2-3개이며 잎같이 보이고 화서보다 길고 옆으로 퍼진다. 화서는 대가 짧은 3-10개의 소수가 산형으로 달려서 두상으로 되며 지름 1.5-3.5cm이다. 줄기는 때로 2~3개의 가지가 갈라지기도 한다. 소수는 편평한 긴 타원형 또는 피침형이고 길이 1-2cm, 폭 2.5-3mm로서 끝이 뾰족하며 15-30개의 꽃이 달린다. 포영은 넓은 난형이고 길이 2-2.5mm로서 끝이 둔하며 양쪽에 홈이 있다. 암술대는 수과보다 3배 정도 길고, 깊게 2개로 갈라진다. 수과는 길이 1mm정도로서 넓은 도란형이며 좌우로 편평하고 확대경으로 볼 수 있는 잔점이 있으며 암갈색이다. 총생하며 세모지고 높이 15~40cm로서 밑부분에서 비스듬히 선다. 아직까지 생리학적 효능이 많이 연구되지는 않았다. Cyperus sanguinolentus is an annual plant distributed throughout the country. The leaves grow at the bottom and are 2-3 mm wide. The bottom is tube-like and shorter than the peduncle. The leaf sheath is green, but the bottom is brown. Flowers bloom from July to October, have 2-3 bracts, look like leaves, and are longer than the inflorescence and spread out laterally. The inflorescence is capitated with 3-10 spikelets with short stems hanging in an umbel shape and has a diameter of 1.5-3.5cm. The stem sometimes splits into 2 or 3 branches. Spikelets are flat, long oval or lanceolate, 1-2 cm long and 2.5-3 mm wide, with pointed ends and 15-30 flowers. The glumes are broadly ovate, 2-2.5mm long, have a blunt end, and have grooves on both sides. The style is about three times longer than the achene and is deeply split into two. The achene is about 1 mm long, has a wide obovate shape, is flat on the left and right, has fine spots that can be seen through a magnifying glass, and is dark brown in color. It grows in groups, is triangular, is 15 to 40 cm high, and stands diagonally at the bottom. The physiological efficacy has not been studied much yet.
이에 본 발명자들은 방동사니대가리 추출물에 관해 다양한 생리활성을 연구하던 중, 상기 추출물이 피부미백 효과가 우수함을 확인하여 본 발명을 완성하였다.Accordingly, while studying various physiological activities of the Bangdong sani head extract, the present inventors confirmed that the extract had an excellent skin whitening effect and completed the present invention.
본 발명의 목적은 방동사니대가리(Cyperus sanguinolentus) 추출물을 함유하는 피부미백용 화장료 조성물을 제공하는 데에 있다.The purpose of the present invention is to provide a cosmetic composition for skin whitening containing Cyperus sanguinolentus extract.
본 발명은 방동사니대가리(Cyperus sanguinolentus) 추출물을 함유하는 피부미백용 화장료 조성물에 관한 것이다. The present invention relates to a cosmetic composition for skin whitening containing Cyperus sanguinolentus extract.
상기 추출물은 티로시나아제를 억제하는 활성이 있다. The extract has tyrosinase inhibitory activity.
상기 추출물은 물, C1~C4 알코올 또는 이들의 혼합용액을 용매로 하여 추출한 것을 특징으로 한다. 상기 C1~C4 알코올은 메탄올, 에탄올, 프로판올, 이소프로판올, 부탄올 및 이소부탄올로 이루어진 군에서 선택될 수 있다. The extract is characterized in that it is extracted using water, C1 to C4 alcohol, or a mixed solution thereof as a solvent. The C1 to C4 alcohol may be selected from the group consisting of methanol, ethanol, propanol, isopropanol, butanol, and isobutanol.
상기 화장료 조성물은, 스킨로션, 스킨 소프트너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스처로션, 영양로션, 맛사지크림, 영양크림, 모이스처크림, 핸드크림, 파운데이션, 에센스, 영양에센스, 팩, 비누, 클렌징폼, 클렌징로션, 클렌징크림, 바디로션 및 바디클린저로 구성된 군으로부터 선택되는 어느 하나의 제형을 가질 수 있다.The cosmetic composition includes skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisture lotion, nutritional lotion, massage cream, nutritional cream, moisture cream, hand cream, foundation, essence, nutritional essence, pack, soap. , it may have any one formulation selected from the group consisting of cleansing foam, cleansing lotion, cleansing cream, body lotion, and body cleanser.
또한, 본 발명은 방동사니대가리 추출물을 함유하는 피부미백용 건강기능식품에 관한 것일 수 있다. Additionally, the present invention may relate to a health functional food for skin whitening containing Bangdong sani head extract.
이하, 본 발명을 상세하게 설명한다.Hereinafter, the present invention will be described in detail.
상기 방동사니대가리 추출물은 채취한 식물의 잎, 줄기와 가지, 헛뿌리, 꽃, 열매, 또는 이들의 혼합물을 추출용매를 이용하여 추출한 것일 수 있다. 바람직하게는 잎과 줄기가 1:0.5 내지 1:2의 중량비로 혼합된 것을 사용할 수 있다. The Bangdong sani head extract may be extracted from the leaves, stems and branches, roots, flowers, fruits, or mixtures thereof of the collected plant using an extraction solvent. Preferably, leaves and stems can be mixed at a weight ratio of 1:0.5 to 1:2.
상기 방동사니대가리 추출물은 물, C1~C4 알코올 또는 이들의 혼합용액을 용매로 하여 제조할 수 있다. 상기 물은 증류수, 이온화수(DI water) 등 불순물이 없는 물이면 어떤 것이든지 사용할 수 있다. 상기 C1~C4 알코올은 메탄올, 에탄올, 프로판올, 이소프로판올, 부탄올 및 이소부탄올로 이루어진 군에서 선택될 수 있다. 이때 방동사니대가리 추출물은 물 추출물보다는 C1~C4 알코올 추출물 또는 C1~C4 알코올의 수용액 추출물인 것이 좋으며, C1~C4 알코올의 수용액 추출물이 피부미백 활성이 가장 좋다. C1~C4 알코올의 수용액으로서 적절한 것은 50 내지 90%(v/v) 에탄올 수용액이며, 가장 적절한 것은 60 내지 70%(v/v) 에탄올 수용액이다. The Bangdong sani head extract can be prepared using water, C1 to C4 alcohol, or a mixed solution thereof as a solvent. The water can be any water without impurities, such as distilled water or ionized water (DI water). The C1 to C4 alcohol may be selected from the group consisting of methanol, ethanol, propanol, isopropanol, butanol, and isobutanol. At this time, it is better to use a C1~C4 alcohol extract or an aqueous solution extract of C1~C4 alcohol rather than a water extract, and the aqueous solution extract of C1~C4 alcohol has the best skin whitening activity. A suitable aqueous solution of C1 to C4 alcohol is a 50 to 90% (v/v) ethanol aqueous solution, and the most suitable is a 60 to 70% (v/v) ethanol aqueous solution.
상기 방동사니대가리 추출물의 제조 시 상기 방동사니대가리 건조 중량의 5 내지 40배, 바람직하게는 10 내지 20배에 달하는 중량의 용매를 이용하여 추출할 수 있다. 상기 범위보다 용매가 너무 적으면 열을 가하여 추출물을 제조할 시, 용매의 증발로 인하여 추출이 잘 안 될 수 있으며, 용매가 너무 많으면 추출시간이 너무 길어지는 문제가 있다.When preparing the Bangdong Sani head extract, it can be extracted using a solvent with a weight of 5 to 40 times, preferably 10 to 20 times, the dry weight of the Bangdong Sani head. If the solvent is too less than the above range, when preparing the extract by applying heat, extraction may be difficult due to evaporation of the solvent, and if the solvent is too much, the extraction time may be too long.
그리고, 상기 추출과정은 10 내지 40℃에서 24 내지 48시간 동안 교반하면서 진행할 수 있으며 1~4번까지 반복하여 추출하여 액상의 추출물을 수득할 수 있다.Additionally, the extraction process can be performed at 10 to 40°C with stirring for 24 to 48 hours, and extraction can be repeated 1 to 4 times to obtain a liquid extract.
상기 액상의 추출물은 멸균 거즈 또는 여과지를 이용하여 건더기 등을 걸러낼 수 있다. 이러한 여과 과정을 통한 여과액은 회전 진공 농축기를 이용하여 10~40℃에서 감압 농축할 수 있고, 동결건조로 남은 용매를 제거한 후 추출물을 수득할 수 있다. The liquid extract can be filtered of dry matter, etc. using sterile gauze or filter paper. The filtrate through this filtration process can be concentrated under reduced pressure at 10-40°C using a rotary vacuum concentrator, and the extract can be obtained after removing the remaining solvent by freeze-drying.
상기 방동사니대가리 추출물은 상기 화장료 조성물에 0.01 내지 20 중량%로 포함할 수 있다. 상기 방동사니대가리 추출물이 화장료 내에 0.01 중량% 미만 포함되면 피부미백 효과가 미미할 수 있고, 20 중량%를 넘으면 제제화가 어려워질 수 있다. 또한, 10 중량%를 넘으면 피부미백 기능성이 향상되는 정도가 미미해질 수 있어서, 상기 방동사니대가리 추출물은 상기 화장료 조성물에 0.01 내지 10 중량%가 포함되는 것이 바람직할 수 있다. 이때 방동사니대가리 추출물의 중량은 상기 방동사니대가리 추출물을 건조하여 분말 형태로 만든 건조된 것을 기준으로 한다.The Bangdongsani head extract may be included in the cosmetic composition in an amount of 0.01 to 20% by weight. If the Bangdongsani head extract is included in the cosmetic in an amount of less than 0.01% by weight, the skin whitening effect may be minimal, and if it exceeds 20% by weight, formulation may become difficult. In addition, if it exceeds 10% by weight, the degree of improvement in skin whitening functionality may become insignificant, so it may be preferable that the cosmetic composition contains 0.01 to 10% by weight of the Bangdong Sanidae Gari extract. At this time, the weight of the Bangdong snake head extract is based on the dried Bangdong snake head extract made into powder form.
또한, 본 발명은 상기 화장료 조성물을 원료 또는 유효성분으로 함유하는 화장료 제형을 제공할 수 있다. 상기 제형은 피부외용연고, 에센스, 미백크림, 로션, 에멀젼, 팩, 일반화장수, 스킨밀크, 스킨, 크림, 세럼, 미용비누, 유연화장수, 약용화장수, 전신세정제, 클렌징 오일, 클렌징 크림, 클렌징 티슈 및 클렌징 워터에서 선택되는 것을 제공할 수 있다. Additionally, the present invention can provide a cosmetic formulation containing the cosmetic composition as a raw material or active ingredient. The above formulations include skin ointment, essence, whitening cream, lotion, emulsion, pack, general lotion, skin milk, skin, cream, serum, beauty soap, softening lotion, medicated lotion, body cleanser, cleansing oil, cleansing cream, and cleansing tissue. and cleansing water.
본 발명의 화장료 제형에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크, 산화아연, 락토스, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트, 폴리아미드 파우더, 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르, 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르, 에톡실화이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트, 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방산 글리세리드, 지방산 디에탄올아미드, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다. The cosmetic formulation of the present invention includes animal oil, vegetable oil, wax, paraffin, starch, tracant, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc, zinc oxide, lactose, silica, aluminum hydroxide, as carrier ingredients. Calcium silicate, polyamide powder, chlorofluorohydrocarbon, propane/butane or dimethyl ether, water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butyl glycol oil, Suspending agents such as glycerol aliphatic esters, fatty acid esters of polyethylene glycol or sorbitan, ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystalline cellulose, aluminum metahydroxide, bentonite, Agar or tracant, aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyl taurate, sarcosinate, fatty acid amide ether sulfate, alkylamidobetaine, fatty acid glyceride. , fatty acid diethanolamide, lanolin derivatives, or ethoxylated glycerol fatty acid esters can be used.
또한, 본 발명은 방동사니대가리 추출물을 함유하는 피부미백용 건강기능식품을 제공한다. In addition, the present invention provides a health functional food for skin whitening containing Bangdong sani head extract.
상기 방동사니대가리 추출물은 본 발명의 건강기능식품에 0.01~100 중량%로 하여 첨가될 수 있다. 본 발명의 건강기능식품은 정제, 캡슐제, 환제 또는 액제 등의 형태를 포함하며, 본 발명의 추출물을 첨가할 수 있는 식품으로는, 예를 들어, 각종 드링크제, 육류, 소세지, 빵, 캔디류, 스넥류, 면류, 아이스크림, 유제품, 스프, 이온음료, 음료수, 알코올 음료, 껌, 차 및 비타민 복합제 등이 있다.The Bangdong sani head extract can be added in an amount of 0.01 to 100% by weight to the health functional food of the present invention. The health functional food of the present invention includes the form of tablets, capsules, pills, or liquid, and foods to which the extract of the present invention can be added include, for example, various drinks, meat, sausages, bread, candy, These include snacks, noodles, ice cream, dairy products, soups, electrolyte beverages, beverages, alcoholic beverages, gum, tea, and vitamin complexes.
본 발명은 방동사니대가리 추출물을 함유하는 조성물에 관한 것으로서, 상기 방동사니대가리의 추출물, 이 중에서도 잎과 줄기 추출물은 티로시나아제의 활성이 우수하여 피부 상태를 개선하는 다기능성 화장료 조성물로 용이하게 이용가능하다. The present invention relates to a composition containing an extract from the head of Bangdong sani, especially the leaf and stem extracts, which have excellent tyrosinase activity and can be easily used as a multifunctional cosmetic composition that improves skin condition. .
이하 본 발명의 바람직한 실시예를 상세히 설명하기로 한다. 그러나, 본 발명은 여기서 설명되는 실시예에 한정되지 않고 다른 형태로 구체화 될 수도 있다. 오히려, 여기서 소개되는 내용이 철저하고 완전해지도록, 당업자에게 본 발명의 사상을 충분히 전달하기 위해 제공하는 것이다.Hereinafter, preferred embodiments of the present invention will be described in detail. However, the present invention is not limited to the embodiments described herein and may be embodied in other forms. Rather, it is provided to ensure that the content introduced here is thorough and complete, and to sufficiently convey the spirit of the present invention to those skilled in the art.
제조예 1 내지 3. 방동사니대가리, 흰방동사니 또는 향부자 추출물의 제조Preparation Examples 1 to 3. Preparation of extracts of Snail head, White Snail or Hyangbuja
본 발명의 방동사니대가리 추출물 제조를 위해, 방동사니대가리의 잎과 줄기를 동량으로 혼합한 것을 3차 증류수를 이용하여 세척하였고, 작두를 이용하여 잘게 분쇄하였다. 분쇄한 방동사니대가리의 잎과 줄기를 동량으로 혼합한 것에 70%(v/v) 에탄올 수용액을 10배 중량 첨가하여 25℃에서 24시간 동안 교반하면서 추출을 진행하였다. 이 후 1차로 멸균 거즈를 이용하여 여과한 후 여과액을 다시 여과지(Whatman, No. 2: Whatman Ltd., Maidstone, Kent, UK)를 이용하여 분쇄 시료 등을 걸러내었고 회전진공농축기를 이용하여 감압 농축한 후 동결건조기로 남은 용매를 제거하여 방동사니대가리 추출물을 수득하였다. 이 외 하기 표 1과 같이 흰방동사니(Cyperus pacificus) 또는 향부자(Cyperus rotundus)에 대해서도 같은 부위의 시료를 이용하여 각각의 추출물을 제조하였다. To prepare the Bangdong sani head extract of the present invention, the leaves and stems of the Bangdong sani head were mixed in equal amounts, washed with tertiary distilled water, and finely ground using a blade. Extraction was performed by adding 10 times the weight of 70% (v/v) ethanol aqueous solution to an equal amount of crushed leaves and stems of Bangdong sani head and stirring at 25°C for 24 hours. After first filtering using sterile gauze, the filtrate was filtered again using filter paper (Whatman, No. 2: Whatman Ltd., Maidstone, Kent, UK) to filter out the ground samples, etc., and then using a rotary vacuum concentrator. After concentration under reduced pressure, the remaining solvent was removed with a freeze dryer to obtain a Bangdong sani head extract. In addition, as shown in Table 1 below, extracts were prepared for Cyperus pacificus or Cyperus rotundus using samples from the same area.
실시예 1. 방동사니대가리 추출물의 티로시나아제 억제 활성 확인 Example 1. Confirmation of tyrosinase inhibitory activity of Bangdongsani head extract
타이로시나아제(Tyrosinase) 저해 활성 측정을 위하여 범용적으로 많이 사용하는 mushroom tyrosinase를 사용하였다. 96-well microplate(SPL Life Sciences Co., Ltd., Pocheon, Korea)에 1 mM L-tyrosine와 0.5 M phosphate buffer(pH 6.5)를 혼합한 용액을 제조한다. 제조한 용액 170 μl와 tyrosinase (300 U) 20 μl에 활성을 측정하고자 하는 추출물 시료들을 25℃에서 30분간 반응시켰다. 반응시킨 후에 microplate reader(Berthold, Bad Wildbad, Germany)를 이용하여 450 nm에서 측정하였다. DMSO 10 μl을 가하여 control로 사용하였다. Blank는 tyrosinase 대신 0.1 M phosphate buffer(pH 6.5) 20 μl를 가하여 측정하였다. To measure tyrosinase inhibitory activity, a widely used mushroom tyrosinase was used. Prepare a solution of 1 mM L-tyrosine and 0.5 M phosphate buffer (pH 6.5) in a 96-well microplate (SPL Life Sciences Co., Ltd., Pocheon, Korea). The extract samples whose activity was to be measured were reacted with 170 μl of the prepared solution and 20 μl of tyrosinase (300 U) at 25°C for 30 minutes. After reaction, it was measured at 450 nm using a microplate reader (Berthold, Bad Wildbad, Germany). 10 μl of DMSO was added and used as a control. Blank was measured by adding 20 μl of 0.1 M phosphate buffer (pH 6.5) instead of tyrosinase.
효소 활성 저해율(%)은 아래와 같은 산출식으로 계산하였다.The enzyme activity inhibition rate (%) was calculated using the formula below.
Tyrosinase 활성 저해율(%) = {(A-B)/A} ×100Tyrosinase activity inhibition rate (%) = {(A-B)/A} ×100
A: O.D at 450 nm without sample A: O.D at 450 nm without sample
B: O.D at 450 nm with sampleB: O.D at 450 nm with sample
(Relative tyrosinase activity, Abs)Relative absorbance compared to control group
(Relative tyrosinase activity, Abs)
확인 결과, 표 2에서와 같이 티로시나아제의 억제 효능이 방동사니대가리 추출물 처리군에서 매우 우수한 것을 확인할 수 있다. 그러나 같은 속 식물인 흰방동사니와 향부자 추출물에서는 그 효능이 거의 나타나지 않았다. As a result, as shown in Table 2, it can be seen that the inhibitory effect of tyrosinase was very excellent in the group treated with the Bangdong snail head extract. However, extracts from the same genus of plants such as P. lily and Hyangbu-ja showed little efficacy.
<제제예 1. 화장료 제조> <Formulation example 1. Cosmetic production>
제제예 1-1. 스킨의 제조Formulation Example 1-1. Manufacturing of Skins
본 발명의 제조예 1의 방동사니대가리 추출물 5.0 중량%, 프로필렌글리콜 5.2 중량%, 올레일알코올 1.5 중량%, 에탄올 3.2 중량%, 폴리솔베이트 20 3.2 중량%, 벤조페논-9 2.0 중량%, 카르복실비닐폴리머 1.0 중량%, 글리세린 3.5 중량% 향 미량, 방부제 미량, 정제수 잔량의 함량으로 하여 통상적인 방법을 사용하여 스킨을 제조하였다.Preparation Example 1 of the present invention contains 5.0% by weight of Bangdongsani head extract, 5.2% by weight of propylene glycol, 1.5% by weight of oleyl alcohol, 3.2% by weight of ethanol, 3.2% by weight of polysorbate 20, 2.0% by weight of benzophenone-9, carboxyl The skin was prepared using a conventional method with the following contents: 1.0% by weight of vinyl polymer, 3.5% by weight of glycerin, a trace amount of fragrance, a trace amount of preservative, and the remaining amount of purified water.
제제예 1-2. 로션의 제조Formulation Example 1-2. Manufacture of lotions
본 발명의 제조예 1의 방동사니대가리 추출물 5.0 중량%, 세토스테아릴 알코올 1.0 중량%, 글리세릴모노스테아레이트 0.8 중량%, 소르비탄모노스테아레이트 0.3 중량%, 폴리솔베이트 60 1.0 중량%, 미네랄오일 5.0 중량%, 사이크로메치콘 3.0 중량%, 디메치콘 0.5 중량%, 알란토인 0.1 중량%, 글리세린 5.0 중량%, 알코올 2 중량%, 프로필렌글리콜 3.0 중량%, 향 미량, 방부제 미량, 정제수 잔량의 함량으로 통상적인 방법을 사용하여 로션을 제조하였다.5.0% by weight of Bangdongsani head extract of Preparation Example 1 of the present invention, 1.0% by weight of cetostearyl alcohol, 0.8% by weight of glyceryl monostearate, 0.3% by weight of sorbitan monostearate, 1.0% by weight of polysorbate 60, mineral oil Typical contents include 5.0% by weight, cyclomethicone 3.0% by weight, dimethicone 0.5% by weight, allantoin 0.1% by weight, glycerin 5.0% by weight, alcohol 2% by weight, propylene glycol 3.0% by weight, a trace amount of flavor, a trace amount of preservative, and the remaining amount of purified water. The lotion was prepared using the phosphorus method.
제제예 1-3. 에센스의 제조Formulation Example 1-3. Preparation of Essence
본 발명의 제조예 1의 방동사니대가리 추출물 5.0 중량%, 프로필렌글리콜 4.0 중량%, 글리세린 3.0 중량%, 알란토인 0.5 중량%, EDTA-2Na 0.01 중량%, 에탄올 5.0 중량%, 트리에탄올아민 1.5 중량%, 스쿠알란 2.0 중량%, 밀랍 2.5 중량%, 폴리솔베이트60 중량%, 카르복실비닐폴리머 1.0 중량%, 솔비탄세스퀴올레이트 2.5 중량%, 향 미량, 방부제 미량, 정제수 잔량의 함량으로 통상적인 방법을 사용하여 에센스를 제조하였다.5.0% by weight of Bangdongsani head extract of Preparation Example 1 of the present invention, 4.0% by weight of propylene glycol, 3.0% by weight of glycerin, 0.5% by weight of allantoin, 0.01% by weight of EDTA-2Na, 5.0% by weight of ethanol, 1.5% by weight of triethanolamine, 2.0% by weight of squalane. Essence using a conventional method with the following contents by weight, 2.5% by weight of beeswax, 60% by weight of polysorbate, 1.0% by weight of carboxylic vinyl polymer, 2.5% by weight of sorbitan sesquioleate, trace amount of fragrance, trace amount of preservative, and remaining amount of purified water. was manufactured.
제제예 1-4. 크림의 제조Formulation Example 1-4. Preparation of Cream
본 발명의 제조예 1의 방동사니대가리 추출물 10.0%, 폴리옥시에틸렌소르비탄모노스테아레이트 0.7%, 솔비탄세스퀴올레이트 0.5%, 세틸알코올 0.6%, 스테아린산 0.75%, 글리세릴모노스테아레이트 0.6%, 유동파라핀 15.0%, 카르복시비닐폴리머 10.0%, 트리에탄올아민 0.2%, 향 미량, 방부제 미량, 정제수 잔량의 함량으로 통상적인 방법을 사용하여 크림을 제조하였다.Preparation Example 1 of the present invention: 10.0% of Bangdong sani head extract, 0.7% of polyoxyethylene sorbitan monostearate, 0.5% of sorbitan sesquioleate, 0.6% of cetyl alcohol, 0.75% of stearic acid, 0.6% of glyceryl monostearate, liquid. A cream was prepared using a conventional method with the following contents: 15.0% paraffin, 10.0% carboxyvinyl polymer, 0.2% triethanolamine, a trace amount of flavor, a trace amount of preservative, and the remaining amount of purified water.
<제제예 2. 식품 제조><Formulation example 2. Food production>
제제예 2-1. 조리용 양념의 제조Formulation Example 2-1. Manufacturing of cooking seasoning
본 발명의 제조예 1의 방동사니대가리 추출물을 조리용 양념에 1 중량%로 첨가하여 건강 증진용 조리용 양념을 제조하였다.A cooking seasoning for health promotion was prepared by adding 1% by weight of the Bangdong sani head extract of Preparation Example 1 of the present invention to the cooking seasoning.
제제예 2-2. 밀가루 식품의 제조Formulation Example 2-2. Manufacturing of flour foods
본 발명의 제조예 1의 방동사니대가리 추출물을 밀가루에 0.1 중량%로 첨가하고, 이 혼합물을 이용하여 빵, 케이크, 쿠키, 크래커 및 면류를 제조하여 건강 증진용 식품을 제조하였다.The extract from Preparation Example 1 of the present invention was added at 0.1% by weight to flour, and this mixture was used to prepare bread, cakes, cookies, crackers, and noodles to prepare food for health promotion.
제제예 2-3. 스프 및 육즙(gravies)의 제조Formulation Example 2-3. Preparation of soups and gravies
본 발명의 제조예 1의 방동사니대가리 추출물을 스프 및 육즙에 0.1 중량%로 첨가하여 건강 증진용 수프 및 육즙을 제조하였다.Health-promoting soup and gravy were prepared by adding 0.1% by weight of the Bangdong sani head extract of Preparation Example 1 of the present invention to soup and gravy.
제제예 2-4. 유제품(dairy products)의 제조Formulation Example 2-4. Manufacturing of dairy products
본 발명의 제조예 1의 방동사니대가리 추출물을 우유에 0.1 중량%로 첨가하고, 상기 우유를 이용하여 버터 및 아이스크림과 같은 다양한 유제품을 제조하였다.The Bangdongsani head extract of Preparation Example 1 of the present invention was added at 0.1% by weight to milk, and various dairy products such as butter and ice cream were manufactured using the milk.
제제예 2-5. 야채주스의 제조Formulation Example 2-5. Manufacturing of vegetable juice
본 발명의 제조예 1의 방동사니대가리 추출물 0.5g을 토마토주스 또는 당근주스 1,000㎖에 가하여 건강 증진용 야채주스를 제조하였다.Vegetable juice for health promotion was prepared by adding 0.5 g of the Bangdong sani head extract of Preparation Example 1 of the present invention to 1,000 ml of tomato juice or carrot juice.
제제예 2-6. 과일주스의 제조Formulation Example 2-6. Manufacturing of fruit juice
본 발명의 제조예 1의 방동사니대가리 추출물 0.1g을 사과주스 또는 포도주스 1,000㎖에 가하여 건강 증진용 과일주스를 제조하였다.Health-promoting fruit juice was prepared by adding 0.1 g of the Bangdong sani head extract of Preparation Example 1 of the present invention to 1,000 ml of apple juice or grape juice.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200167170A KR102596573B1 (en) | 2020-12-03 | 2020-12-03 | Cosmetic composition containing Cyperus sanguinolentus extract for skin whitening |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200167170A KR102596573B1 (en) | 2020-12-03 | 2020-12-03 | Cosmetic composition containing Cyperus sanguinolentus extract for skin whitening |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20220078061A KR20220078061A (en) | 2022-06-10 |
KR102596573B1 true KR102596573B1 (en) | 2023-10-31 |
Family
ID=81986478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200167170A KR102596573B1 (en) | 2020-12-03 | 2020-12-03 | Cosmetic composition containing Cyperus sanguinolentus extract for skin whitening |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102596573B1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6321760A (en) * | 1986-07-15 | 1988-01-29 | Fuji Electric Co Ltd | Fuel cell power generating system |
KR100751883B1 (en) | 2006-09-07 | 2007-08-23 | 주식회사 웰스킨 | Whitening composition containing gamma linolenic acid and 4-n-butylresorcinol water-soluble nanoliposome |
KR20150026579A (en) | 2013-09-03 | 2015-03-11 | (주) 와이디생명과학 | Pharmaceutical Composition and heath care food comprising the extract of complex herb an active ingredient for preventing and treating allergic or non-allergic skin disease |
KR101908221B1 (en) | 2017-03-21 | 2018-12-11 | 동의대학교 산학협력단 | Compositions for anti-obesity comprising extract of Cyperus microiria Steud. |
-
2020
- 2020-12-03 KR KR1020200167170A patent/KR102596573B1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR20220078061A (en) | 2022-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101393007B1 (en) | Cosmetic Composition for Skin-aging Protection and Wrinkle Improvement Comprising the Extract of Nephelium lappaceum and Litchi chinensis sonn as Active Ingredient | |
KR101828584B1 (en) | Composition containing complex extracts including Veratrum nigrum var. ussuriense, Juglans mandshurica, Rodgersia podophylla and Chaenomeles sinensis with antioxidant activity or whitening | |
KR102360585B1 (en) | Method for preparilng aloe extract comprising high concentration of phenolic compound and skin regeneration, anti-inflammatory and/or anti-oxidant composition comprising the same | |
JP2021502953A (en) | Cosmetic composition for skin whitening and wrinkle improvement containing Centella asiatica extract as an active ingredient | |
KR102355143B1 (en) | Method for preparing fermentated ziziphus jujuba seed | |
KR102539209B1 (en) | Cosmetic composition for skin-whitening, anti-oxidant, anti-inflammatory, skin anti-irritation and moisturizing comprising the extract of Nymphaea alba, Backhousia citriodora and Malus pumila | |
KR101781545B1 (en) | A cosmetic composition for skin whitening comprising the extract of saccharina japonica as active ingredient | |
KR102425559B1 (en) | Composition for improving skin comprising an extract of Pueraria thomsonii or a compound derived therefrom | |
KR102596573B1 (en) | Cosmetic composition containing Cyperus sanguinolentus extract for skin whitening | |
KR102471009B1 (en) | Cosmetic composition containing Albiggia kalkora extract for skin whitening and improving wrinkles | |
KR102526287B1 (en) | Composition for anti-inflammation and anti-wrinkle comprising fermentative product of Gryllus bimaculatus extract as effective component | |
KR102149223B1 (en) | Cosmetic composition for skin whitening containing the fermented complex natural extracts | |
KR102154139B1 (en) | Composition comprising fermentation of sap of painted maple, cacao nibs extract and granat extract | |
KR101618180B1 (en) | Cosmetic composition comprising an extract of the tissue-cultured raoulia australis shoot | |
KR102128168B1 (en) | Composition comprising the extract of Lentinula edodes and Acer pictum subsp. mono leaf for antioxidant effect | |
KR101786853B1 (en) | Cosmetic composition for skin whitening comprising the extract of Caragana Sinica | |
KR101889492B1 (en) | composition containing complex extract of Morus alba for pendula, Prunus salicina and Oenothera lamarckiana | |
KR102471026B1 (en) | Cosmetic composition containing Cyperus spp. extract for antiinflammation or skin whitening | |
KR102313083B1 (en) | An anti-oxidative composition comprising an extract of Hydrangea petiolaris or a fraction thereof as an active ingredient | |
KR20150010530A (en) | A cosmetic composition comprising critical extracts of pear | |
KR102651353B1 (en) | Composition for anti-oxidation and whitening comprising golden crocus extract, and use thereof | |
KR102326086B1 (en) | Composition for Improving Skin Conditions Having Skin Whitening, Moisturizing, Anti-Wrinkle and Skin Barrier Property Comprising Complex Extracts of Broussonetia kazinoki as Active Ingredient | |
KR102589938B1 (en) | Composition for anti-oxidant, anti-inflammation, whitening and anti-wrinkle comprising fermented Hibiscus manihot as effective component | |
KR102534239B1 (en) | Cosmetic composition comprising glutathione, Maqui Berry extract and Mulberry root extract | |
KR102355138B1 (en) | Composition for whitening or anti-wrinkle of the skin comprising fermentated ziziphus jujuba seed as effective component |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant |